Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test Gadgeel, S., Soria, J. C., Goldman, J. W., Wakelee, H., Camidge, D. R., Yu, H., Varga, A., Solomon, B., Oxnard, G. R., Ou, S. H., Papadimitrakopoulou, V., Liu, S. V., Reckamp, K., Spira, A., Piotrowska, Z., Despain, D., Karlovich, C., Yurasov, S., Sequist, L. V. ELSEVIER SCI LTD. 2015: S628
View details for DOI 10.1016/S0959-8049(16)31729-4
View details for Web of Science ID 000361887403046